Advanced genomic testing could help erase significant disparities in breast cancer survival rates between white and Black ...

The journey through a breast cancer diagnosis is often described as a series of mountains with each one taller than the last.

Lucy Liu shares how a misdiagnosis led to surgery and changed how she advocates for her own health.

A discovery by the Transformation and Metastasis Group of the Spanish National Cancer Research Center (CNIO) opens a path ...

A recent study examines the association between COVID-19 infection and an increased risk of recurrence in breast cancer ...

All asymptomatic women aged 50 to 74 years at an average risk for breast cancer should receive biennial screening mammography, new ACP guidance published in Annals of Internal Medicine states. Carolyn ...

Fraser Symmans explains how ctDNA is replacing CTCs to monitor breast cancer, detect mutations and track minimal residual ...

The risks and benefits of hormone replacement therapy use for menopausal symptoms in breast cancer survivors are examined in light of recent research.

Understanding which cells within a tumor will go on to form metastases remains one of the major challenges in cancer research ...

NCCN now recognizes image-only, mammogram-derived AI as a primary risk tool, shifting risk stratification from ...

Hayley Knollman, MD, explains how ctDNA and genomic testing impact ER-positive metastatic breast cancer care, guiding ...